From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- PMID: 28264912
- DOI: 10.1530/ERC-17-0004
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
Abstract
The classification of neoplasms of adenohypophysial cells is misleading because of the simplistic distinction between adenoma and carcinoma, based solely on metastatic spread and the poor reproducibility and predictive value of the definition of atypical adenomas based on the detection of mitoses or expression of Ki-67 or p53. In addition, the current classification of neoplasms of the anterior pituitary does not accurately reflect the clinical spectrum of behavior. Invasion and regrowth of proliferative lesions and persistence of hormone hypersecretion cause significant morbidity and mortality. We propose a new terminology, pituitary neuroendocrine tumor (PitNET), which is consistent with that used for other neuroendocrine neoplasms and which recognizes the highly variable impact of these tumors on patients.
Keywords: nomenclature; pituitary tumors.
© 2017 Society for Endocrinology.
Similar articles
-
How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies.Front Endocrinol (Lausanne). 2021 Mar 17;12:604644. doi: 10.3389/fendo.2021.604644. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815274 Free PMC article. Review.
-
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary.Acta Neuropathol. 2017 Oct;134(4):521-535. doi: 10.1007/s00401-017-1769-8. Epub 2017 Aug 18. Acta Neuropathol. 2017. PMID: 28821944 Review.
-
Comprehensive Classification of Surgically Resected Pituitary Neuroendocrine Tumors: Updates From a Single-Institution Experience Based on the WHO 5th Edition.J Korean Med Sci. 2025 Apr 28;40(16):e56. doi: 10.3346/jkms.2025.40.e56. J Korean Med Sci. 2025. PMID: 40296825 Free PMC article.
-
Newer Concepts in the Classification of Pituitary Adenomas.Neurol India. 2020 May-Jun;68(Supplement):S7-S12. doi: 10.4103/0028-3886.287667. Neurol India. 2020. PMID: 32611886 Review.
-
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.Mod Pathol. 2021 Sep;34(9):1634-1650. doi: 10.1038/s41379-021-00820-y. Epub 2021 May 21. Mod Pathol. 2021. PMID: 34017065 Review.
Cited by
-
Drug Repositioning for Refractory Benign Tumors of the Central Nervous System.Int J Mol Sci. 2023 Aug 20;24(16):12997. doi: 10.3390/ijms241612997. Int J Mol Sci. 2023. PMID: 37629179 Free PMC article. Review.
-
MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.Int J Mol Sci. 2020 Apr 18;21(8):2831. doi: 10.3390/ijms21082831. Int J Mol Sci. 2020. PMID: 32325698 Free PMC article.
-
High-Grade Ectopic Pituitary Adenoma within the Cerebellopontine Angle: A Case Report.J Neurol Surg Rep. 2023 Apr 21;84(2):e51-e58. doi: 10.1055/a-2065-9809. eCollection 2023 Apr. J Neurol Surg Rep. 2023. PMID: 37090942 Free PMC article.
-
Impact of metabolic syndrome on postoperative outcomes of transsphenoidal pituitary surgery: analysis of U.S. nationwide inpatient sample data 2005-2018.Front Endocrinol (Lausanne). 2024 Mar 25;15:1235441. doi: 10.3389/fendo.2024.1235441. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38590825 Free PMC article.
-
SLC7A11 promotes EMT and metastasis in invasive pituitary neuroendocrine tumors by activating the PI3K/AKT signaling pathway.Endocr Connect. 2024 Jun 3;13(7):e240097. doi: 10.1530/EC-24-0097. Print 2024 Jul 1. Endocr Connect. 2024. PMID: 38722255 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous